- Home
- TRX vs PMVP Comparison
TRX vs PMVP Comparison
Compare TRX & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRX
- PMVP
- Stock Information
- Founded
- TRX 1990
- PMVP 2013
- Country
- TRX Canada
- PMVP United States
- Employees
- TRX N/A
- PMVP N/A
- Industry
- TRX
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- TRX
- PMVP Health Care
- Exchange
- TRX Nasdaq
- PMVP Nasdaq
- Market Cap
- TRX 95.9M
- PMVP 77.4M
- IPO Year
- TRX N/A
- PMVP 2020
- Fundamental
- Price
- TRX $0.52
- PMVP $1.25
- Analyst Decision
- TRX Strong Buy
- PMVP Strong Buy
- Analyst Count
- TRX 1
- PMVP 1
- Target Price
- TRX $1.10
- PMVP $5.00
- AVG Volume (30 Days)
- TRX 1.3M
- PMVP 2.7M
- Earning Date
- TRX 07-15-2025
- PMVP 11-06-2025
- Dividend Yield
- TRX N/A
- PMVP N/A
- EPS Growth
- TRX N/A
- PMVP N/A
- EPS
- TRX N/A
- PMVP N/A
- Revenue
- TRX $47,731,000.00
- PMVP N/A
- Revenue This Year
- TRX $23.64
- PMVP N/A
- Revenue Next Year
- TRX $51.77
- PMVP N/A
- P/E Ratio
- TRX $498.50
- PMVP N/A
- Revenue Growth
- TRX 29.98
- PMVP N/A
- 52 Week Low
- TRX $0.27
- PMVP $0.81
- 52 Week High
- TRX $0.55
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- TRX 80.75
- PMVP 43.37
- Support Level
- TRX $0.51
- PMVP $1.12
- Resistance Level
- TRX $0.55
- PMVP $1.40
- Average True Range (ATR)
- TRX 0.03
- PMVP 0.16
- MACD
- TRX 0.01
- PMVP -0.03
- Stochastic Oscillator
- TRX 84.35
- PMVP 17.94
About TRX TRX Gold Corporation
TRX Gold Corp is a mineral resource company. It is engaged in the acquisition of interests and the exploration of natural resource properties. Its mineral properties are located in the United Republic of Tanzania. The company's main area of interest has been in the exploration and development of gold properties. It is focused on the Buckreef Gold Project which comprises five prospects, namely Buckreef, Bingwa, Tembo, Eastern Porphyry, and Buziba.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.